Your browser doesn't support javascript.
loading
Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma.
Mamatjan, Yasin; Voisin, Mathew R; Nassiri, Farshad; Moraes, Fabio Y; Bunda, Severa; So, Jonathan; Salih, Mira; Shirahata, Mitsuaki; Ono, Takahiro; Shimizu, Hiroaki; Schrimpf, Daniel; von Deimling, Andreas; Aldape, Kenneth D; Zadeh, Gelareh.
Afiliación
  • Mamatjan Y; Princess Margaret Cancer Center and MacFeeters-Hamilton Center for Neuro-Oncology Research, University Health Network, Toronto, Ontario, Canada.
  • Voisin MR; Faculty of Science, Thompson Rivers University, Kamloops, British Columbia, Canada.
  • Nassiri F; Princess Margaret Cancer Center and MacFeeters-Hamilton Center for Neuro-Oncology Research, University Health Network, Toronto, Ontario, Canada.
  • Moraes FY; Princess Margaret Cancer Center and MacFeeters-Hamilton Center for Neuro-Oncology Research, University Health Network, Toronto, Ontario, Canada.
  • Bunda S; Department of Oncology, Queens University, Kingston, Ontario, Canada.
  • So J; Princess Margaret Cancer Center and MacFeeters-Hamilton Center for Neuro-Oncology Research, University Health Network, Toronto, Ontario, Canada.
  • Salih M; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Shirahata M; Mount Sinai Hospital, New York, New York, USA.
  • Ono T; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Shimizu H; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Schrimpf D; Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan.
  • von Deimling A; Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan.
  • Aldape KD; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Zadeh G; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Neuro Oncol ; 25(11): 2028-2041, 2023 11 02.
Article en En | MEDLINE | ID: mdl-37474126
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido